PatchSiren

PatchSiren cyber security CVE debrief

CVE-2026-94035 SourceCodester CVE debrief

A vulnerability was determined in SourceCodester Drug Recommendation System 1.0. Impacted is an unknown function of the file /drug_recommender/index.php. Executing a manipulation of the argument full name can lead to cross site scripting. The attack can be launched remotely. The exploit has been publicly disclosed and may be utilized. Defenders should assess their exposure and prioritize verification of the presence of this vulnerability in their inventory. The vulnerability class is cross-site scripting, and the likely operational impact is unauthorized actions on behalf of users.

Vendor
SourceCodester
Product
Drug Recommendation System
CVSS
LOW 2.1
CISA KEV
Not listed in stored evidence
Original CVE published
2026-09-20
Original CVE updated
2026-09-20
Advisory published
2026-09-20
Advisory updated
2026-09-20

Who should care

Defenders responsible for the SourceCodester Drug Recommendation System 1.0 should assess their exposure and prioritize verification of the presence of this vulnerability in their inventory.

Why it matters

CVE-2026-94035 is a cross-site scripting vulnerability in SourceCodester Drug Recommendation System 1.0 that can be exploited remotely. Defenders should prioritize verifying the presence of this vulnerability in their inventory and assessing the potential impact on their systems.

  • Cross-site scripting attacks can lead to unauthorized actions on behalf of users
  • Defenders should verify the presence of this vulnerability in their inventory
  • The scope of affected versions and potential impact require further verification

Technical summary

The vulnerability is located in the /drug_recommender/index.php file of the SourceCodester Drug Recommendation System 1.0. An attacker can exploit this vulnerability by manipulating the 'full name' argument, leading to cross-site scripting attacks. The vulnerability class is cross-site scripting, and the likely operational impact is unauthorized actions on behalf of users. Defenders should prioritize verifying the presence of this vulnerability in their inventory and assessing the potential impact on their systems.

Defensive priority

Defenders should prioritize verifying the presence of this vulnerability in their inventory and assessing the potential impact on their systems.

Recommended defensive actions

  • Verify the presence of this vulnerability in your inventory
  • Assess the potential impact on your systems
  • Consider implementing compensating controls to mitigate the vulnerability
  • Review relevant monitoring, detection, and logs for exposed assets that need extra review
  • Track exceptions, retest remediated assets, and close the item only after evidence is documented
  • Plan vendor-supported updates or mitigations through normal change control where exposure is confirmed
  • Confirm whether affected product deployments exist in managed environments and assign an owner for follow-up

Evidence notes

The CVE record and NVD vulnerability detail page provide information on the vulnerability, but the scope of affected versions and potential impact require further verification. The source confidence is limited, and defenders should verify the presence of this vulnerability in their inventory. The affected product is SourceCodester Drug Recommendation System 1.0, and the vulnerability is located in the /drug_recommender/index.php file.

Sources and references

Verified primary and authoritative sources

  • CVE-2026-94035 CVE Program record

    Publisher, destination, and source semantics verified

    URL: https://www.cve.org/CVERecord?id=CVE-2026-94035

    CVE Program - Official CVE Program record with source-provided CVE metadata.

  • CVE-2026-94035 NVD vulnerability detail

    Publisher, destination, and source semantics verified

    URL: https://nvd.nist.gov/vuln/detail/CVE-2026-94035

    NIST National Vulnerability Database - Official NIST NVD detail page and source-specific vulnerability assessment.

Supplemental references

Methodology and review provenance

AI-assisted synthesis based on stored public vulnerability evidence. System validation, approval state, and publication status do not by themselves establish human review of this revision. PatchSiren helps prioritize defensive review and does not prove exposure or remediation on any system.